Simone Brogi

60PUBLICATIONS
141CO-AUTHORS
Haematological tumoursCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Jul 04, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4.

|Jun 29, 2026
Integrated structure-based and fragment-guided design of isonicotinic acid derivatives as potential KDM4A inhibitors: an in silico study.

|Apr 24, 2026
Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model.

|Apr 06, 2026
Dimeric Anthraquinone Rugulosin A Induces Apoptosis in Lung Adenocarcinoma and Targets PI3K/AKT/MAPK Pathways In Silico.

Joe Anthony H Manzano, Elian Angelo M Abellanosa, Jose Paolo P Aguilar

|Mar 20, 2026
Second-generation prokineticin PKR1 receptor agonists: Advancing cardioprotection against chemotherapy-induced toxicity.

Anais Audebrand, Simone Brogi, Mustafa Tezeren

|Feb 23, 2026
Quinazolinone-Based PqsR Modulators Suppress Quorum-Sensing-Driven Virulence in Pseudomonas aeruginosa.

Valeria Tudino, Marta Mellini, Leonardo Milioni

Pageof 10

Frequent Collaborators

18 joint publications

Sandra Gemma

16 joint publications

Stefania Butini

14 joint publications

Giuseppe Campiani

12 joint publications

Gabriele Carullo